rusted Supplier of High-Quality Rituximab Biosimilar for Global Healthcare Markets
Cordium Pharmaceuticals Pvt Ltd, India, is a leading global exporter and supplier of Rituximab Biosimilar 100mg and 500mg injections, delivering reliable oncology and immunotherapy solutions to hospitals, clinics, pharmacies, distributors, and personal import buyers worldwide.
We ensure WHO-GMP quality standards, cold-chain compliance, and fast international delivery to key regions including South Africa (Gauteng, Western Cape, KwaZulu-Natal, Eastern Cape, Free State) and other global markets.
What is Rituximab Biosimilar Injection?
Rituximab is a monoclonal antibody (anti-CD20 therapy) used in the treatment of various cancers and autoimmune diseases. The biosimilar versions provide the same clinical efficacy and safety profile as the originator biologic, making them a cost-effective alternative for global healthcare systems.
It works by targeting CD20-positive B-lymphocytes, helping the immune system destroy abnormal or overactive cells.
Available Strengths
Rituximab Biosimilar 100mg Injection
Rituximab Biosimilar 500mg Injection
These strengths are widely used in hospital oncology protocols and immunotherapy regimens across international healthcare systems.
Key Medical Indications
Rituximab Biosimilar is commonly prescribed for:
Non-Hodgkin’s Lymphoma (NHL)
Chronic Lymphocytic Leukemia (CLL)
Rheumatoid Arthritis (RA)
Granulomatosis with Polyangiitis (GPA)
Microscopic Polyangiitis (MPA)
It is widely used in oncology treatment protocols and autoimmune disease management globally.
Dosage & Administration
Administered as intravenous (IV) infusion only
Given under strict medical supervision in hospitals or clinics
Dosage depends on:
Patient condition
Body surface area
Treatment protocol
Pre-medication may be required to reduce infusion-related reactions
⚠️ Prescription-only medication. Must be administered by qualified healthcare professionals.
Key Benefits of Rituximab Biosimilar
Cost-effective alternative to reference biologics
High therapeutic efficacy in oncology and autoimmune diseases
WHO-GMP certified manufacturing partners
Global regulatory compliance support
Cold-chain controlled export packaging (2°C–8°C)
Trusted supply chain for international healthcare markets
Global Export Coverage
Cordium Pharmaceuticals Pvt Ltd supplies Rituximab Biosimilar injections to:
🌍 South Africa (Gauteng, Western Cape, KwaZulu-Natal, Eastern Cape, Free State)
🇺🇸 USA
🇬🇧 UK
🇦🇪 UAE
🇨🇦 Canada
🌏 Europe, Asia, and Africa
We support hospital procurement, wholesale distributors, NGOs, and personal import buyers with reliable documentation and export compliance.
Storage & Handling
Store at 2°C to 8°C (refrigerated conditions)
Do not freeze
Protect from light
Maintain cold-chain during transportation
Keep out of reach of unauthorized handling
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted Indian pharmaceutical exporter
Specialization in oncology & biologic therapies
Fast global shipping network
Secure packaging and cold-chain logistics
Competitive export pricing
End-to-end documentation support
Applications in Modern Medicine
Rituximab biosimilar is widely used in:
Oncology treatment protocols (R-CHOP regimens)
Autoimmune disease therapy
Hematological malignancies
Immunotherapy-based treatment strategies
It plays a critical role in improving patient outcomes in B-cell related disorders.
Contact for Orders & Enquiries
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
🌍 Cordium Pharmaceuticals Pvt Ltd – Global Export Division (India)
Cordium Pharmaceuticals Pvt Ltd, India, is a leading global exporter and supplier of Rituximab Biosimilar 100mg and 500mg injections, delivering reliable oncology and immunotherapy solutions to hospitals, clinics, pharmacies, distributors, and personal import buyers worldwide.
We ensure WHO-GMP quality standards, cold-chain compliance, and fast international delivery to key regions including South Africa (Gauteng, Western Cape, KwaZulu-Natal, Eastern Cape, Free State) and other global markets.
What is Rituximab Biosimilar Injection?
Rituximab is a monoclonal antibody (anti-CD20 therapy) used in the treatment of various cancers and autoimmune diseases. The biosimilar versions provide the same clinical efficacy and safety profile as the originator biologic, making them a cost-effective alternative for global healthcare systems.
It works by targeting CD20-positive B-lymphocytes, helping the immune system destroy abnormal or overactive cells.
Available Strengths
Rituximab Biosimilar 100mg Injection
Rituximab Biosimilar 500mg Injection
These strengths are widely used in hospital oncology protocols and immunotherapy regimens across international healthcare systems.
Key Medical Indications
Rituximab Biosimilar is commonly prescribed for:
Non-Hodgkin’s Lymphoma (NHL)
Chronic Lymphocytic Leukemia (CLL)
Rheumatoid Arthritis (RA)
Granulomatosis with Polyangiitis (GPA)
Microscopic Polyangiitis (MPA)
It is widely used in oncology treatment protocols and autoimmune disease management globally.
Dosage & Administration
Administered as intravenous (IV) infusion only
Given under strict medical supervision in hospitals or clinics
Dosage depends on:
Patient condition
Body surface area
Treatment protocol
Pre-medication may be required to reduce infusion-related reactions
⚠️ Prescription-only medication. Must be administered by qualified healthcare professionals.
Key Benefits of Rituximab Biosimilar
Cost-effective alternative to reference biologics
High therapeutic efficacy in oncology and autoimmune diseases
WHO-GMP certified manufacturing partners
Global regulatory compliance support
Cold-chain controlled export packaging (2°C–8°C)
Trusted supply chain for international healthcare markets
Global Export Coverage
Cordium Pharmaceuticals Pvt Ltd supplies Rituximab Biosimilar injections to:
🌍 South Africa (Gauteng, Western Cape, KwaZulu-Natal, Eastern Cape, Free State)
🇺🇸 USA
🇬🇧 UK
🇦🇪 UAE
🇨🇦 Canada
🌏 Europe, Asia, and Africa
We support hospital procurement, wholesale distributors, NGOs, and personal import buyers with reliable documentation and export compliance.
Storage & Handling
Store at 2°C to 8°C (refrigerated conditions)
Do not freeze
Protect from light
Maintain cold-chain during transportation
Keep out of reach of unauthorized handling
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted Indian pharmaceutical exporter
Specialization in oncology & biologic therapies
Fast global shipping network
Secure packaging and cold-chain logistics
Competitive export pricing
End-to-end documentation support
Applications in Modern Medicine
Rituximab biosimilar is widely used in:
Oncology treatment protocols (R-CHOP regimens)
Autoimmune disease therapy
Hematological malignancies
Immunotherapy-based treatment strategies
It plays a critical role in improving patient outcomes in B-cell related disorders.
Contact for Orders & Enquiries
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
🌍 Cordium Pharmaceuticals Pvt Ltd – Global Export Division (India)
Keywords
